Lindbrook Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $45.9K | Sell |
205
-15
| -7% | -$3.36K | ﹤0.01% | 1050 |
|
|
2024
Q4 | $72.1K | Buy |
220
+65
| +42% | +$21.3K | 0.01% | 665 |
|
|
2024
Q3 | $46.5K | Sell |
155
-63
| -29% | -$18.9K | ﹤0.01% | 855 |
|
|
2024
Q2 | $71.8K | Sell |
218
-19
| -8% | -$6.26K | 0.01% | 652 |
|
|
2024
Q1 | $93.8K | Buy |
237
+2
| +0.9% | +$791 | 0.01% | 553 |
|
|
2023
Q4 | $82.7K | Buy |
235
+74
| +46% | +$26.1K | 0.01% | 579 |
|
|
2023
Q3 | $60.4K | Buy |
161
+2
| +1% | +$750 | 0.01% | 617 |
|
|
2023
Q2 | $60.8K | Sell |
159
-22
| -12% | -$8.41K | 0.01% | 638 |
|
|
2023
Q1 | $62.7K | Buy |
181
+106
| +141% | +$36.7K | 0.01% | 609 |
|
|
2022
Q4 | $17.7K | Sell |
75
-40
| -35% | -$9.41K | ﹤0.01% | 1125 |
|
|
2022
Q3 | $28K | Buy |
115
+47
| +69% | +$11.4K | ﹤0.01% | 850 |
|
|
2022
Q2 | $21K | Buy |
68
+14
| +26% | +$4.32K | ﹤0.01% | 956 |
|
|
2022
Q1 | $22K | Sell |
54
-1
| -2% | -$407 | ﹤0.01% | 973 |
|
|
2021
Q4 | $26K | Sell |
55
-4
| -7% | -$1.89K | ﹤0.01% | 934 |
|
|
2021
Q3 | $25K | Buy |
59
+9
| +18% | +$3.81K | 0.01% | 667 |
|
|
2021
Q2 | $18K | Buy |
50
+3
| +6% | +$1.08K | ﹤0.01% | 831 |
|
|
2021
Q1 | $13K | Buy |
47
+15
| +47% | +$4.15K | ﹤0.01% | 923 |
|
|
2020
Q4 | $9K | Hold |
32
| – | – | ﹤0.01% | 967 |
|
|
2020
Q3 | $9K | Buy |
32
+6
| +23% | +$1.69K | ﹤0.01% | 886 |
|
|
2020
Q2 | $6K | Hold |
26
| – | – | ﹤0.01% | 1045 |
|
|
2020
Q1 | $4K | Hold |
26
| – | – | ﹤0.01% | 1124 |
|
|
2019
Q4 | $4K | Hold |
26
| – | – | ﹤0.01% | 1176 |
|
|
2019
Q3 | $4K | Hold |
26
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q1 | $2K | Hold |
26
| – | – | ﹤0.01% | 1253 |
|
|
2018
Q4 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 1203 |
|